The global market for G-CSF Biosimilars was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for G-CSF Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G-CSF Biosimilars.

The G-CSF Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global G-CSF Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the G-CSF Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of G-CSF Biosimilars Market Report

Report Metric	Details
Report Name	G-CSF Biosimilars Market
CAGR	5%
Segment by Type	Human Growth Hormone Erythropoietin Monoclonal Antibodies Insulin Interferon Granulocyte-Colony Stimulating Factor
Segment by Application	Blood Disorders Oncology Diseases Chronic And Autoimmune Diseases Growth Hormone Deficiencies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of G-CSF Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of G-CSF Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the G-CSF Biosimilars Market report?

Ans: The main players in the G-CSF Biosimilars Market are Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline, AbbVie, Amgen, AstraZeneca, Bayer

What are the Application segmentation covered in the G-CSF Biosimilars Market report?

Ans: The Applications covered in the G-CSF Biosimilars Market report are Blood Disorders, Oncology Diseases, Chronic And Autoimmune Diseases, Growth Hormone Deficiencies

What are the Type segmentation covered in the G-CSF Biosimilars Market report?

Ans: The Types covered in the G-CSF Biosimilars Market report are Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor

1 G-CSF Biosimilars Market Overview

1.1 Product Definition

1.2 G-CSF Biosimilars by Type

1.2.1 Global G-CSF Biosimilars Market Value Comparison by Type (2024 VS 2031)

1.2.2 Human Growth Hormone

1.2.3 Erythropoietin

1.2.4 Monoclonal Antibodies

1.2.5 Insulin

1.2.6 Interferon

1.2.7 Granulocyte-Colony Stimulating Factor

1.3 G-CSF Biosimilars by Application

1.3.1 Global G-CSF Biosimilars Market Value by Application (2024 VS 2031)

1.3.2 Blood Disorders

1.3.3 Oncology Diseases

1.3.4 Chronic And Autoimmune Diseases

1.3.5 Growth Hormone Deficiencies

1.4 Global G-CSF Biosimilars Market Size Estimates and Forecasts

1.4.1 Global G-CSF Biosimilars Revenue 2020-2031

1.4.2 Global G-CSF Biosimilars Sales 2020-2031

1.4.3 Global G-CSF Biosimilars Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 G-CSF Biosimilars Market Competition by Manufacturers

2.1 Global G-CSF Biosimilars Sales Market Share by Manufacturers (2020-2025)

2.2 Global G-CSF Biosimilars Revenue Market Share by Manufacturers (2020-2025)

2.3 Global G-CSF Biosimilars Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of G-CSF Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of G-CSF Biosimilars, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of G-CSF Biosimilars, Product Type & Application

2.7 Global Key Manufacturers of G-CSF Biosimilars, Date of Enter into This Industry

2.8 Global G-CSF Biosimilars Market Competitive Situation and Trends

2.8.1 Global G-CSF Biosimilars Market Concentration Rate

2.8.2 The Global 5 and 10 Largest G-CSF Biosimilars Players Market Share by Revenue

2.8.3 Global G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global G-CSF Biosimilars Market Scenario by Region

3.1 Global G-CSF Biosimilars Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global G-CSF Biosimilars Sales by Region: 2020-2031

3.2.1 Global G-CSF Biosimilars Sales by Region: 2020-2025

3.2.2 Global G-CSF Biosimilars Sales by Region: 2026-2031

3.3 Global G-CSF Biosimilars Revenue by Region: 2020-2031

3.3.1 Global G-CSF Biosimilars Revenue by Region: 2020-2025

3.3.2 Global G-CSF Biosimilars Revenue by Region: 2026-2031

3.4 North America G-CSF Biosimilars Market Facts & Figures by Country

3.4.1 North America G-CSF Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America G-CSF Biosimilars Sales by Country (2020-2031)

3.4.3 North America G-CSF Biosimilars Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe G-CSF Biosimilars Market Facts & Figures by Country

3.5.1 Europe G-CSF Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe G-CSF Biosimilars Sales by Country (2020-2031)

3.5.3 Europe G-CSF Biosimilars Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific G-CSF Biosimilars Market Facts & Figures by Region

3.6.1 Asia Pacific G-CSF Biosimilars Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific G-CSF Biosimilars Sales by Region (2020-2031)

3.6.3 Asia Pacific G-CSF Biosimilars Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America G-CSF Biosimilars Market Facts & Figures by Country

3.7.1 Latin America G-CSF Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America G-CSF Biosimilars Sales by Country (2020-2031)

3.7.3 Latin America G-CSF Biosimilars Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa G-CSF Biosimilars Market Facts & Figures by Country

3.8.1 Middle East and Africa G-CSF Biosimilars Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa G-CSF Biosimilars Sales by Country (2020-2031)

3.8.3 Middle East and Africa G-CSF Biosimilars Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global G-CSF Biosimilars Sales by Type (2020-2031)

4.1.1 Global G-CSF Biosimilars Sales by Type (2020-2025)

4.1.2 Global G-CSF Biosimilars Sales by Type (2026-2031)

4.1.3 Global G-CSF Biosimilars Sales Market Share by Type (2020-2031)

4.2 Global G-CSF Biosimilars Revenue by Type (2020-2031)

4.2.1 Global G-CSF Biosimilars Revenue by Type (2020-2025)

4.2.2 Global G-CSF Biosimilars Revenue by Type (2026-2031)

4.2.3 Global G-CSF Biosimilars Revenue Market Share by Type (2020-2031)

4.3 Global G-CSF Biosimilars Price by Type (2020-2031)

5 Segment by Application

5.1 Global G-CSF Biosimilars Sales by Application (2020-2031)

5.1.1 Global G-CSF Biosimilars Sales by Application (2020-2025)

5.1.2 Global G-CSF Biosimilars Sales by Application (2026-2031)

5.1.3 Global G-CSF Biosimilars Sales Market Share by Application (2020-2031)

5.2 Global G-CSF Biosimilars Revenue by Application (2020-2031)

5.2.1 Global G-CSF Biosimilars Revenue by Application (2020-2025)

5.2.2 Global G-CSF Biosimilars Revenue by Application (2026-2031)

5.2.3 Global G-CSF Biosimilars Revenue Market Share by Application (2020-2031)

5.3 Global G-CSF Biosimilars Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer G-CSF Biosimilars Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis G-CSF Biosimilars Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Roche

6.3.1 Roche Company Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Roche G-CSF Biosimilars Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Merck & Co.

6.4.1 Merck & Co. Company Information

6.4.2 Merck & Co. Description and Business Overview

6.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck & Co. G-CSF Biosimilars Product Portfolio

6.4.5 Merck & Co. Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Company Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sanofi G-CSF Biosimilars Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Johnson & Johnson

6.6.1 Johnson & Johnson Company Information

6.6.2 Johnson & Johnson Description and Business Overview

6.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Johnson & Johnson G-CSF Biosimilars Product Portfolio

6.6.5 Johnson & Johnson Recent Developments/Updates

6.7 Gilead Science

6.7.1 Gilead Science Company Information

6.7.2 Gilead Science Description and Business Overview

6.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Gilead Science G-CSF Biosimilars Product Portfolio

6.7.5 Gilead Science Recent Developments/Updates

6.8 GlaxoSmithKline

6.8.1 GlaxoSmithKline Company Information

6.8.2 GlaxoSmithKline Description and Business Overview

6.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.8.4 GlaxoSmithKline G-CSF Biosimilars Product Portfolio

6.8.5 GlaxoSmithKline Recent Developments/Updates

6.9 AbbVie

6.9.1 AbbVie Company Information

6.9.2 AbbVie Description and Business Overview

6.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.9.4 AbbVie G-CSF Biosimilars Product Portfolio

6.9.5 AbbVie Recent Developments/Updates

6.10 Amgen

6.10.1 Amgen Company Information

6.10.2 Amgen Description and Business Overview

6.10.3 Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Amgen G-CSF Biosimilars Product Portfolio

6.10.5 Amgen Recent Developments/Updates

6.11 AstraZeneca

6.11.1 AstraZeneca Company Information

6.11.2 AstraZeneca Description and Business Overview

6.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.11.4 AstraZeneca G-CSF Biosimilars Product Portfolio

6.11.5 AstraZeneca Recent Developments/Updates

6.12 Bayer

6.12.1 Bayer Company Information

6.12.2 Bayer Description and Business Overview

6.12.3 Bayer G-CSF Biosimilars Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Bayer G-CSF Biosimilars Product Portfolio

6.12.5 Bayer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 G-CSF Biosimilars Industry Chain Analysis

7.2 G-CSF Biosimilars Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 G-CSF Biosimilars Production Mode & Process Analysis

7.4 G-CSF Biosimilars Sales and Marketing

7.4.1 G-CSF Biosimilars Sales Channels

7.4.2 G-CSF Biosimilars Distributors

7.5 G-CSF Biosimilars Customer Analysis

8 G-CSF Biosimilars Market Dynamics

8.1 G-CSF Biosimilars Industry Trends

8.2 G-CSF Biosimilars Market Drivers

8.3 G-CSF Biosimilars Market Challenges

8.4 G-CSF Biosimilars Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global G-CSF Biosimilars Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global G-CSF Biosimilars Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global G-CSF Biosimilars Market Competitive Situation by Manufacturers in 2024

Table 4. Global G-CSF Biosimilars Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global G-CSF Biosimilars Sales Market Share by Manufacturers (2020-2025)

Table 6. Global G-CSF Biosimilars Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global G-CSF Biosimilars Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market G-CSF Biosimilars Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of G-CSF Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of G-CSF Biosimilars, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of G-CSF Biosimilars, Product Type & Application

Table 12. Global Key Manufacturers of G-CSF Biosimilars, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global G-CSF Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF Biosimilars as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global G-CSF Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global G-CSF Biosimilars Sales by Region (2020-2025) & (K Units)

Table 18. Global G-CSF Biosimilars Sales Market Share by Region (2020-2025)

Table 19. Global G-CSF Biosimilars Sales by Region (2026-2031) & (K Units)

Table 20. Global G-CSF Biosimilars Sales Market Share by Region (2026-2031)

Table 21. Global G-CSF Biosimilars Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global G-CSF Biosimilars Revenue Market Share by Region (2020-2025)

Table 23. Global G-CSF Biosimilars Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global G-CSF Biosimilars Revenue Market Share by Region (2026-2031)

Table 25. North America G-CSF Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America G-CSF Biosimilars Sales by Country (2020-2025) & (K Units)

Table 27. North America G-CSF Biosimilars Sales by Country (2026-2031) & (K Units)

Table 28. North America G-CSF Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America G-CSF Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe G-CSF Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe G-CSF Biosimilars Sales by Country (2020-2025) & (K Units)

Table 32. Europe G-CSF Biosimilars Sales by Country (2026-2031) & (K Units)

Table 33. Europe G-CSF Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe G-CSF Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific G-CSF Biosimilars Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific G-CSF Biosimilars Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific G-CSF Biosimilars Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific G-CSF Biosimilars Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific G-CSF Biosimilars Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America G-CSF Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America G-CSF Biosimilars Sales by Country (2020-2025) & (K Units)

Table 42. Latin America G-CSF Biosimilars Sales by Country (2026-2031) & (K Units)

Table 43. Latin America G-CSF Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America G-CSF Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa G-CSF Biosimilars Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa G-CSF Biosimilars Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa G-CSF Biosimilars Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa G-CSF Biosimilars Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa G-CSF Biosimilars Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global G-CSF Biosimilars Sales (K Units) by Type (2020-2025)

Table 51. Global G-CSF Biosimilars Sales (K Units) by Type (2026-2031)

Table 52. Global G-CSF Biosimilars Sales Market Share by Type (2020-2025)

Table 53. Global G-CSF Biosimilars Sales Market Share by Type (2026-2031)

Table 54. Global G-CSF Biosimilars Revenue (US$ Million) by Type (2020-2025)

Table 55. Global G-CSF Biosimilars Revenue (US$ Million) by Type (2026-2031)

Table 56. Global G-CSF Biosimilars Revenue Market Share by Type (2020-2025)

Table 57. Global G-CSF Biosimilars Revenue Market Share by Type (2026-2031)

Table 58. Global G-CSF Biosimilars Price (USD/Unit) by Type (2020-2025)

Table 59. Global G-CSF Biosimilars Price (USD/Unit) by Type (2026-2031)

Table 60. Global G-CSF Biosimilars Sales (K Units) by Application (2020-2025)

Table 61. Global G-CSF Biosimilars Sales (K Units) by Application (2026-2031)

Table 62. Global G-CSF Biosimilars Sales Market Share by Application (2020-2025)

Table 63. Global G-CSF Biosimilars Sales Market Share by Application (2026-2031)

Table 64. Global G-CSF Biosimilars Revenue (US$ Million) by Application (2020-2025)

Table 65. Global G-CSF Biosimilars Revenue (US$ Million) by Application (2026-2031)

Table 66. Global G-CSF Biosimilars Revenue Market Share by Application (2020-2025)

Table 67. Global G-CSF Biosimilars Revenue Market Share by Application (2026-2031)

Table 68. Global G-CSF Biosimilars Price (USD/Unit) by Application (2020-2025)

Table 69. Global G-CSF Biosimilars Price (USD/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer G-CSF Biosimilars Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Novartis G-CSF Biosimilars Product

Table 79. Novartis Recent Developments/Updates

Table 80. Roche Company Information

Table 81. Roche Description and Business Overview

Table 82. Roche G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Roche G-CSF Biosimilars Product

Table 84. Roche Recent Developments/Updates

Table 85. Merck & Co. Company Information

Table 86. Merck & Co. Description and Business Overview

Table 87. Merck & Co. G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck & Co. G-CSF Biosimilars Product

Table 89. Merck & Co. Recent Developments/Updates

Table 90. Sanofi Company Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Sanofi G-CSF Biosimilars Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Johnson & Johnson Company Information

Table 96. Johnson & Johnson Description and Business Overview

Table 97. Johnson & Johnson G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Johnson & Johnson G-CSF Biosimilars Product

Table 99. Johnson & Johnson Recent Developments/Updates

Table 100. Gilead Science Company Information

Table 101. Gilead Science Description and Business Overview

Table 102. Gilead Science G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Gilead Science G-CSF Biosimilars Product

Table 104. Gilead Science Recent Developments/Updates

Table 105. GlaxoSmithKline Company Information

Table 106. GlaxoSmithKline Description and Business Overview

Table 107. GlaxoSmithKline G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. GlaxoSmithKline G-CSF Biosimilars Product

Table 109. GlaxoSmithKline Recent Developments/Updates

Table 110. AbbVie Company Information

Table 111. AbbVie Description and Business Overview

Table 112. AbbVie G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. AbbVie G-CSF Biosimilars Product

Table 114. AbbVie Recent Developments/Updates

Table 115. Amgen Company Information

Table 116. Amgen Description and Business Overview

Table 117. Amgen G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Amgen G-CSF Biosimilars Product

Table 119. Amgen Recent Developments/Updates

Table 120. AstraZeneca Company Information

Table 121. AstraZeneca Description and Business Overview

Table 122. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. AstraZeneca G-CSF Biosimilars Product

Table 124. AstraZeneca Recent Developments/Updates

Table 125. Bayer Company Information

Table 126. Bayer Description and Business Overview

Table 127. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Bayer G-CSF Biosimilars Product

Table 129. Bayer Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. G-CSF Biosimilars Distributors List

Table 133. G-CSF Biosimilars Customers List

Table 134. G-CSF Biosimilars Market Trends

Table 135. G-CSF Biosimilars Market Drivers

Table 136. G-CSF Biosimilars Market Challenges

Table 137. G-CSF Biosimilars Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of G-CSF Biosimilars

Figure 2. Global G-CSF Biosimilars Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global G-CSF Biosimilars Market Share by Type: 2024 & 2031

Figure 4. Human Growth Hormone Product Picture

Figure 5. Erythropoietin Product Picture

Figure 6. Monoclonal Antibodies Product Picture

Figure 7. Insulin Product Picture

Figure 8. Interferon Product Picture

Figure 9. Granulocyte-Colony Stimulating Factor Product Picture

Figure 10. Global G-CSF Biosimilars Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global G-CSF Biosimilars Market Share by Application: 2024 & 2031

Figure 12. Blood Disorders

Figure 13. Oncology Diseases

Figure 14. Chronic And Autoimmune Diseases

Figure 15. Growth Hormone Deficiencies

Figure 16. Global G-CSF Biosimilars Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global G-CSF Biosimilars Market Size (2020-2031) & (US$ Million)

Figure 18. Global G-CSF Biosimilars Sales (2020-2031) & (K Units)

Figure 19. Global G-CSF Biosimilars Average Price (USD/Unit) & (2020-2031)

Figure 20. G-CSF Biosimilars Report Years Considered

Figure 21. G-CSF Biosimilars Sales Share by Manufacturers in 2024

Figure 22. Global G-CSF Biosimilars Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest G-CSF Biosimilars Players: Market Share by Revenue in G-CSF Biosimilars in 2024

Figure 24. G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global G-CSF Biosimilars Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America G-CSF Biosimilars Sales Market Share by Country (2020-2031)

Figure 27. North America G-CSF Biosimilars Revenue Market Share by Country (2020-2031)

Figure 28. U.S. G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe G-CSF Biosimilars Sales Market Share by Country (2020-2031)

Figure 31. Europe G-CSF Biosimilars Revenue Market Share by Country (2020-2031)

Figure 32. Germany G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific G-CSF Biosimilars Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific G-CSF Biosimilars Revenue Market Share by Region (2020-2031)

Figure 39. China G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America G-CSF Biosimilars Sales Market Share by Country (2020-2031)

Figure 50. Latin America G-CSF Biosimilars Revenue Market Share by Country (2020-2031)

Figure 51. Mexico G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa G-CSF Biosimilars Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa G-CSF Biosimilars Revenue Market Share by Country (2020-2031)

Figure 56. Turkey G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E G-CSF Biosimilars Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of G-CSF Biosimilars by Type (2020-2031)

Figure 60. Global Revenue Market Share of G-CSF Biosimilars by Type (2020-2031)

Figure 61. Global G-CSF Biosimilars Price (USD/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of G-CSF Biosimilars by Application (2020-2031)

Figure 63. Global Revenue Market Share of G-CSF Biosimilars by Application (2020-2031)

Figure 64. Global G-CSF Biosimilars Price (USD/Unit) by Application (2020-2031)

Figure 65. G-CSF Biosimilars Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions